Moreover, intraperitoneal injection of the compound in a syngeneic mouse tumor model led to decreased tumor growth in human PD-L-1 transfected murine melanoma and lung cancer, enhanced tumor infiltrating CD8+ cell abundance, and reduced tumor and FoxP3+ CD4+ cell abundance expressing PD-L-1. This evidence concerns the gene FOXP3 and neoplasm.